{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:46:26Z","timestamp":1791272786131,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI1006I"],"award-info":[{"award-number":["01KI1006I"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.antiviral.2013.06.008","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T02:31:01Z","timestamp":1372386661000},"page":"336-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus"],"prefix":"10.1016","volume":"99","author":[{"given":"Emanuel","family":"Haasbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Julia","family":"Reiling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Droebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"R\u00fcckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike R.","family":"Hrincius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Leban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Vitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Planz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.06.008_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.resp.2010.11.004","article-title":"Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm","volume":"175","author":"Cheng","year":"2011","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.06.008_b0015","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1016\/j.vaccine.2008.09.051","article-title":"Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain","volume":"26","author":"Droebner","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.06.008_b0020","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1128\/JVI.01071-08","article-title":"Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection","volume":"82","author":"Droebner","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0025","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1128\/JVI.00533-10","article-title":"The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state","volume":"84","author":"Dudek","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0170","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/cmi.12108","article-title":"The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance","volume":"15","author":"Ehrhardt","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.151.5.951","article-title":"Caspases disrupt the nuclear-cytoplasmic barrier","volume":"151","author":"Faleiro","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0040","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/AAC.01667-08","article-title":"Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model","volume":"53","author":"Govorkova","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.06.008_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.06.008_b0050","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.0801967105","article-title":"Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina","volume":"105","author":"Kramer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.06.008_b0055","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.bmcl.2007.08.022","article-title":"A novel class of potent NF-kappaB signaling inhibitors","volume":"17","author":"Leban","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2013.06.008_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkp161","article-title":"Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy","volume":"64","author":"Ludwig","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.06.008_b0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/BC.2011.121","article-title":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections","volume":"392","author":"Ludwig","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.06.008_b0070","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1515\/BC.2008.148","article-title":"Influenza viruses and the NF-kappaB signaling pathway \u2013 towards a novel concept of antiviral therapy","volume":"389","author":"Ludwig","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.06.008_b0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1462-5822.2005.00678.x","article-title":"Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells","volume":"8","author":"Ludwig","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1057\/jphp.2011.51","article-title":"Lessons from SARS and H1N1\/A: employing a WHO-WTO forum to promote optimal economic-public health pandemic response","volume":"33","author":"Mackey","year":"2012","journal-title":"J. Public Health Policy"},{"key":"10.1016\/j.antiviral.2013.06.008_b0085","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0090","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2011.06.113","article-title":"Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries","volume":"29","author":"Monto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.06.008_b0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jac\/dkq100","article-title":"Targeting pandemic influenza: a primer on influenza antivirals and drug resistance","volume":"65","author":"Moss","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.06.008_b0100","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/vir.0.79958-0","article-title":"Active NF-kappaB signalling is a prerequisite for influenza virus infection","volume":"85","author":"Nimmerjahn","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0105","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2013.06.008_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2011.09.024","article-title":"Prospects for controlling future pandemics of influenza","volume":"162","author":"Robertson","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.06.008_b0115","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1073\/pnas.0705289104","article-title":"Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection","volume":"104","author":"Salomon","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.06.008_b0120","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.4049\/jimmunol.0804198","article-title":"Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome","volume":"183","author":"Schmolke","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(97)00065-X","article-title":"Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor","volume":"37","author":"Sidwell","year":"1998","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.06.008_b0130","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/AAC.01012-08","article-title":"Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice","volume":"53","author":"Smee","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.06.008_b0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mo.l Biol. Rev."},{"key":"10.1016\/j.antiviral.2013.06.008_b0140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/0002018-200831120-00006","article-title":"Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review","volume":"31","author":"Toovey","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.antiviral.2013.06.008_b0145","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.06.008_b0150","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1189\/jlb.1203644","article-title":"Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice","volume":"76","author":"Wareing","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2013.06.008_b0155","doi-asserted-by":"crossref","first-page":"30931","DOI":"10.1074\/jbc.M403258200","article-title":"NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas\/FasL is crucial for efficient influenza virus propagation","volume":"279","author":"Wurzer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.06.008_b0160","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/emboj\/cdg279","article-title":"Caspase 3 activation is essential for efficient influenza virus propagation","volume":"22","author":"Wurzer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.06.008_b0165","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","article-title":"Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus","volume":"105","author":"Zheng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213001654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:13Z","timestamp":1759062373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213001654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0166354213001654"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.06.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}